Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Hong Kong · Delayed Price · Currency is HKD 7.43
-0.04 (-0.47%)
Nov 11, 2026, 4:08 PM HKT
HKG:1858 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 916.15 | 1,046 | 805.86 | 1,209 | 1,202 | 1,108 |
Revenue Growth | -13.05% | 29.77% | -33.32% | 0.58% | 8.43% | 18.18% |
Gross Profit Gross Profit Growth | 548.4 | 653.4 | 516.49 | 855.18 | 900.08 | 844.03 |
Operating Income Operating Income Growth | 254.76 | 270.27 | 91.96 | 261.3 | 281.35 | 344.44 |
Net Income Net Income Growth | 269.57 | 272.54 | 124.99 | 277.82 | 307.72 | 322.36 |
Earnings Per Share EPS Growth | 0.70 | 0.71 | 0.33 | 0.72 | 0.80 | 0.93 |
EPS Growth | 3.98% | 115.15% | -54.17% | -10.00% | -13.98% | 13.41% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Device Products Medical Device Products Growth | 1,045 | 805.22 | 1,209 | 1,202 | 1,108 |
Unallocated Other Unallocated Other Growth | 0.8 | 0.64 | - | - | - |
Total Total Growth | 1,046 | 805.86 | 1,209 | 1,202 | 1,108 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,171 | 2,220 | 1,886 | 2,098 | 1,725 | 1,736 |
Total Debt Total Debt Growth | 2.39 | 3.28 | 0.87 | 1.75 | 1.31 | 1.23 |
Net Cash (Debt) Net Cash Growth | 2,169 | 2,217 | 1,885 | 2,097 | 1,724 | 1,735 |
Net Cash Growth | 8.71% | 17.64% | -10.11% | 21.64% | -0.67% | 152.17% |
Net Cash Per Share Net Cash Per Share Growth | 5.63 | 5.78 | 4.98 | 5.43 | 4.48 | 5.01 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 347.79 | 404.84 | -1.9 | 511.71 | 41.01 | 164.79 |
Capital Expenditures CapEx Growth | -42.16 | -59.13 | -49.17 | -33.24 | -24.9 | -199.41 |
Free Cash Flow Free Cash Flow Growth | 305.63 | 345.71 | -51.07 | 478.47 | 16.1 | -34.62 |
Free Cash Flow Growth | 145.49% | - | - | 2871.30% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.86% | 62.48% | 64.09% | 70.76% | 74.91% | 76.17% |
Operating Margin | 27.81% | 25.84% | 11.41% | 21.62% | 23.41% | 31.08% |
Pretax Margin | 33.01% | 28.85% | 16.33% | 25.31% | 28.04% | 33.15% |
Profit Margin | 29.42% | 26.06% | 15.51% | 22.99% | 25.61% | 29.09% |
FCF Margin | 33.36% | 33.06% | -6.34% | 39.59% | 1.34% | -3.12% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.304 | 0.360 | 0.132 | 0.362 | 0.313 | 0.130 |
Dividend Per Share Growth | 177.13% | 172.73% | -63.54% | 15.65% | 140.77% | - |
Dividend Yield | 4.10% | 1.75% | 1.14% | 1.60% | 1.46% | 0.55% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.07 | 28.76 | 35.56 | 31.18 | 26.68 | 28.17 |
Forward PE | 9.30 | 19.82 | 10.02 | 12.89 | 14.67 | 11.29 |
P/FCF Ratio | 14.56 | 22.67 | - | 18.10 | 509.88 | - |
PS Ratio | 4.86 | 7.50 | 5.52 | 7.17 | 6.83 | 8.20 |